Summary: Incannex Healthcare Inc announced it has entered into a financing agreement with Arena Investors LP, securing up to $10 million in convertible notes and a $50 million equity line of credit. The funds will be used to advance clinical trials for its lead product, IHL-42X, … [Read more...]
Inspire Secures Reimbursement for OSA Therapy in France
Summary: Inspire Medical Systems, a company specializing in minimally invasive solutions for obstructive sleep apnea, announced the approval of reimbursement for its Inspire therapy in France. The therapy, which received European Conformity Marking in 2010, has already secured … [Read more...]
NLS Pharmaceutics Secures Patent for Dual Orexin Receptor Agonists
Summary: NLS Pharmaceutics Ltd announced the publication of a new patent application by Aexon Labs with the World Intellectual Property Organization, introducing a novel series of dual orexin receptor agonists. These compounds are designed to treat narcolepsy and … [Read more...]
Fullpower-AI Secures New Patents to Enhance Sleep with AI
Summary: Fullpower-AI has secured 5 new patents from the US Patent and Trademark Business, boosting its portfolio in sleep and wellness innovation. The patents focus on various technologies which includes a sounds-resilient snooze details assortment program, a non-get hold of … [Read more...]
Harmony Secures Rights to Develop Bioprojet’s Orexin-2 Agonist
Summary: Harmony Biosciences has secured an unique license from Bioprojet to establish, manufacture, and commercialize TPM-1116, an oral orexin-2 receptor agonist, in the United States and Latin The united states. This drug, aimed at dealing with narcolepsy and other rest … [Read more...]
NLS Secures Exclusive License for Dual Orexin Agonist Platform
Swiss biopharmaceutical enterprise NLS Pharmaceutics Ltd declared an exclusive worldwide license arrangement with Aexon Labs Inc, a US-centered biotech agency, to purchase global advancement and commercialization legal rights to Aexon’s twin orexin receptor agonists system. These … [Read more...]